UNSPSC 51432510: Perindopril arginine

This classification denotes an ace inhibitor C19H32N2O5.C6H14N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TFT5IM1KGB, chemically known as l-arginine, (2s,3as,7as)-1-((2s)-2-(((1s)-1-(ethoxycarbonyl)butyl]amino)-1-oxopropyl)octahydro-1h-indole-2-carboxylate (1:1), but more generally known as perindopril arginine, which bears US NIH Compound Identifier 12068809. European Medicines Agency schedules Perindopril arginine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23191.

Most nations, for tariff and trade purposes, schedule perindopril arginine under HS 29339990 and SITC 51577. As of Q4 2014, PERINDOPRIL ARGININE remains US FDA's Preferred Term for this commodity. SMILES: CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O.C(C[C@@H](C(=O)O)N)CNC(=N)N.

UNSPSC 51432510 Perindopril arginine is a Commodity code that captures individual pharmaceutical products — in this case, a specific antihypertensive medication — purchased by state and local health agencies, fire-rescue departments, and cooperative purchasing alliances for use in emergency medical services, hospital formularies, and multi-state pharmacy benefit programs. The code covers the supply of branded or generic active pharmaceutical ingredients and finished medications to public sector health systems, with recent solicitations showing demand for both emergency-use medications (such as those procured by fire departments) and bulk generic pharmaceuticals distributed through authorized wholesaler networks to multiple state and local facilities.

State and local issuing bodies under this code include individual cities (Tampa Fire Rescue through the City of Tampa), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and other participating jurisdictions). Recent activity spans the South (Florida), Southwest (Texas), and Upper Midwest (Minnesota and Oregon). Representative opportunities include the City of Tampa's IFB for Advanced Life Support Medications (Solicitation 26P00188, response due April 8, 2026, estimated value $40,000) supplying labetalol, epinephrine, adenosine, and diltiazem to Tampa Fire Rescue with one-year term and optional two-year renewal; the Texas HHS Commission's RFI on Direct-to-Manufacturer Prescriptions (HHS0017013, posted April 3, 2026) exploring direct contracting models for pharmacy benefit programs; and the Minnesota Department of Administration's RFP through MMCAP for Generic Multi-Source Pharmaceuticals and OTC Products (S1070000015802, due March 26, 2026) establishing multistate contracts effective July 1, 2026, with pricing weighted 75 percent on price competitiveness and vendors required to maintain relationships with authorized wholesalers AmerisourceBergen, Cardinal Health, and Morris & Dickson.